BACKGROUND: Acute lung injury complicates approximately 25-30% of subjects undergoing oesophagectomy. Experimental studies suggest that treatment with beta agonists may prevent the development of acute lung injury by decreasing inflammatory cell infiltration, activation and inflammatory cytokine release, enhancing basal alveolar fluid clearance and improving alveolar capillary barrier function. METHODS/DESIGN: The Beta Agonist Lung Injury TrIal (prevention) is a multi-centre, randomised, doub...Expand abstract
- Publication status:
- Publisher copy:
- Copyright date:
The Beta Agonist Lung Injury TrIal (BALTI)--prevention trial protocol.
If you are the owner of this record, you can report an update to it here: Report update to this record